-
RNXT Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
RenovoRx (RNXT)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 9.56 mm | 9.56 mm | 9.56 mm | 9.56 mm | 9.56 mm | 9.56 mm |
Cash burn (monthly) | 726.33 k | (no burn) | 942.67 k | 842.92 k | 731.33 k | 729.00 k |
Cash used (since last report) | 2.93 mm | n/a | 3.80 mm | 3.40 mm | 2.95 mm | 2.94 mm |
Cash remaining | 6.64 mm | n/a | 5.76 mm | 6.17 mm | 6.62 mm | 6.63 mm |
Runway (months of cash) | 9.1 | n/a | 6.1 | 7.3 | 9.0 | 9.1 |
13F holders | Current |
---|---|
Total holders | 6 |
Opened positions | 2 |
Closed positions | 7 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 291.05 mm |
Total shares | 1.53 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Kamran Najmabadi | 731.25 k | $3.54 mm |
BSX Boston Scientific | 543.97 k | $2.63 mm |
Geode Capital Management | 143.92 k | $162.65 mm |
Nixon Peabody Trust | 97.17 k | $109.80 mm |
Renaissance Technologies | 10.00 k | $11.30 mm |
Family Firm | 1.00 k | $1.13 mm |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Oct 24 | Kirsten Angela Macfarlane | Stock Options Common Stock | Grant | Acquire A | No | No | 1.02 | 25,099 | 25.60 k | 25,099 |
1 Oct 24 | Una S Ryan | Stock Options Common Stock | Grant | Acquire A | No | No | 1.02 | 25,099 | 25.60 k | 25,099 |
1 Oct 24 | Laurence Marton | Stock Options Common Stock | Grant | Acquire A | No | No | 1.02 | 25,099 | 25.60 k | 25,099 |
1 Oct 24 | Spiegel Robert J. | Stock Options Common Stock | Grant | Acquire A | No | No | 1.02 | 25,099 | 25.60 k | 25,099 |
6 Mar 24 | Leesa Gentry | Options Common Stock | Grant | Acquire A | No | No | 1.69 | 190,000 | 321.10 k | 190,000 |